These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25683142)

  • 1. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
    Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
    World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.
    Di Paolo V; Russo I; Boldrini R; Ravà L; Pezzullo M; Benedetti MC; Galardi A; Colletti M; Rota R; Orlando D; Crocoli A; Peinado H; Milano GM; Di Giannatale A
    BMC Cancer; 2018 Jan; 18(1):31. PubMed ID: 29304781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival.
    Sugita Y; Takase Y; Mori D; Tokunaga O; Nakashima A; Shigemori M
    J Neurooncol; 2007 May; 82(3):249-56. PubMed ID: 17102906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Ishikawa S; Wada H
    Lung Cancer; 2003 Mar; 39(3):289-96. PubMed ID: 12609567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.
    Kyzas PA; Agnantis NJ; Stefanou D
    Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
    Behrem S; Zarkovic K; Eskinja N; Jonjic N
    Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs.
    Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C
    J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
    Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
    APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor origin of endothelial cells in human neuroblastoma.
    Pezzolo A; Parodi F; Corrias MV; Cinti R; Gambini C; Pistoia V
    J Clin Oncol; 2007 Feb; 25(4):376-83. PubMed ID: 17264333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
    Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
    Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
    Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of endoglin (CD105) expression in ovarian carcinoma.
    Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H
    Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.